Literature DB >> 22447032

Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.

Hideyuki Nakaoka1, Hirokazu Kanegane, Hiromichi Taneichi, Kazushi Miya, Xi Yang, Keiko Nomura, Shunichiro Takezaki, Masafumi Yamada, Osamu Ohara, Chikako Kamae, Kohsuke Imai, Shigeaki Nonoyama, Taizo Wada, Akihiro Yachie, Michael S Hershfield, Tadashi Ariga, Toshio Miyawaki.   

Abstract

Acute disseminated encephalomyelitis (ADEM) is a monophasic, immune-mediated demyelinating disorder that can appear after either immunizations or, more often, infections. Magnetic resonance imaging of patients shows inflammatory lesions in the brain and spinal cord. An immune-mediated mechanism may play a role in this disease, although its precise pathogenesis remains unclear. In this study, a 2-year-old boy presented with ADEM, and he showed improvement on treatment with high-dose intravenous corticosteroids. At the age of 3 years, the presence of recurrent bronchitis, bronchiectasia, and lymphopenia suggested that the patient was suffering from combined immunodeficiency. The patient was finally diagnosed with delayed onset adenosine deaminase deficiency. Delayed onset adenosine deaminase deficiency is frequently associated with autoimmune diseases, including thyroiditis and cytopenia, both of which were observed in the patient. The ADEM in this patient may be a presentation of delayed onset adenosine deaminase deficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447032     DOI: 10.1007/s12185-012-1055-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Acute disseminated encephalomyelitis as manifestation of primary HIV infection.

Authors:  P Narciso; S Galgani; B Del Grosso; M De Marco; A De Santis; P Balestra; V Ciapparoni; V Tozzi
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

2.  Acute demyelinating encephalomyelitis (ADEM) in a patient with HIV infection.

Authors:  S H Allen; O Malik; M C I Lipman; M A Johnson; L A Wilson
Journal:  J Infect       Date:  2002-07       Impact factor: 6.072

3.  Acute demyelinizating encephalomyelitis (ADEM) as initial presentation of primary HIV infection.

Authors:  Trine H Mogensen; Edvard Marinovskij; Carsten S Larsen
Journal:  Scand J Infect Dis       Date:  2007

4.  T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation.

Authors:  T Ariga; N Oda; K Yamaguchi; N Kawamura; H Kikuta; S Taniuchi; Y Kobayashi; K Terada; H Ikeda; M S Hershfield; K Kobayashi; Y Sakiyama
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

5.  Acute demyelinating encephalomyelitis (ADEM), cryptococcal reactivation and disseminated Herpes simplex in an HIV infected child following HAART.

Authors:  Ronald van Toorn; Fiona Kritzinger; Helena Rabie
Journal:  Eur J Paediatr Neurol       Date:  2005-06-23       Impact factor: 3.140

6.  A common variable immunodeficient patient who developed acute disseminated encephalomyelitis followed by the Lennox-Gastaut syndrome.

Authors:  Masashi Kondo; Toshiyuki Fukao; Takahide Teramoto; Hideo Kaneko; Yukitoshi Takahashi; Hiroyuki Okamoto; Naomi Kondo
Journal:  Pediatr Allergy Immunol       Date:  2005-06       Impact factor: 6.377

7.  Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.

Authors:  M S Hershfield; R H Buckley; M L Greenberg; A L Melton; R Schiff; C Hatem; J Kurtzberg; M L Markert; R H Kobayashi; A L Kobayashi
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

Review 8.  Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.

Authors:  Russell C Dale; Fabienne Brilot; Brenda Banwell
Journal:  Curr Opin Neurol       Date:  2009-06       Impact factor: 5.710

9.  Establishment and characterization of adenosine deaminase-deficient human T cell lines.

Authors:  D B Kohn; H Mitsuya; M Ballow; J E Selegue; J Barankiewicz; A Cohen; E Gelfand; W F Anderson; R M Blaese
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

10.  Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.

Authors:  F X Arredondo-Vega; I Santisteban; S Daniels; S Toutain; M S Hershfield
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

View more
  1 in total

1.  Heterozygous Mutation in Adenosine Deaminase Gene in a Patient With Severe Lymphopenia Following Corticosteroid Treatment of Autoimmune Hemolytic Anemia.

Authors:  Serena I Tripodi; Paola Corti; Silvia Giliani; Arnalda Lanfranchi; Andrea Biondi; Raffaele Badolato
Journal:  Front Pediatr       Date:  2018-10-01       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.